| Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent G Srinivas, S Babykutty, PP Sathiadevan, P Srinivas Medicinal research reviews 27 (5), 591-608, 2007 | 376 | 2007 |
| Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9 G Srinivas, RJ Anto, P Srinivas, S Vidhyalakshmi, VP Senan, ... European journal of pharmacology 473 (2-3), 117-125, 2003 | 256 | 2003 |
| Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells P Srinivas, G Gopinath, A Banerji, A Dinakar, G Srinivas Molecular Carcinogenesis: Published in cooperation with the University of …, 2004 | 235 | 2004 |
| Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-κB P Suboj, S Babykutty, DRV Gopi, RS Nair, P Srinivas, S Gopala European journal of pharmaceutical sciences 45 (5), 581-591, 2012 | 165 | 2012 |
| Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP‐2/9 expression via inhibiting ERK1/2 and reducing DNA‐binding activity of NF‐κB in … S Babykutty, P PS, N RJ, MAS Kumar, MS Nair, P Srinivas, S Gopala Molecular carcinogenesis 51 (6), 475-490, 2012 | 133 | 2012 |
| Apoptosis induction of Centella asiatica on human breast cancer cells S Babykutty, J Padikkala, P Sathiadevan, V Vijayakurup, T Azis, ... African Journal of Traditional, Complementary and Alternative Medicines 6 (1), 2009 | 121 | 2009 |
| Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo S Sinha, K Pal, A Elkhanany, S Dutta, Y Cao, G Mondal, S Iyer, ... International Journal of Cancer 132 (5), 1201-1212, 2013 | 119 | 2013 |
| Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways S Babykutty, P Suboj, P Srinivas, AS Nair, K Chandramohan, S Gopala Clinical & experimental metastasis 29, 471-492, 2012 | 108 | 2012 |
| Radiosensitizing effects of plumbagin in cervical cancer cells is through modulation of apoptotic pathway S Nair, RRK Nair, P Srinivas, G Srinivas, MR Pillai Molecular Carcinogenesis: Published in cooperation with the University of …, 2008 | 102 | 2008 |
| Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents KA Thasni, S Rakesh, G Rojini, T Ratheeshkumar, G Srinivas, S Priya Annals of oncology 19 (4), 696-705, 2008 | 96 | 2008 |
| Aloe emodin induces G2/M cell cycle arrest and apoptosis via activation of caspase-6 in human colon cancer cells P Suboj, S Babykutty, P Srinivas, S Gopala Pharmacology 89 (1-2), 91-98, 2012 | 80 | 2012 |
| Cadherins as predictive markers of nodal metastasis in breast cancer M Madhavan, P Srinivas, E Abraham, I Ahmed, A Mathew, ... Modern Pathology 14 (5), 423-427, 2001 | 73 | 2001 |
| Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG‐1 ovarian cancer cells G Srinivas, LA Annab, G Gopinath, A Banerji, P Srinivas Molecular Carcinogenesis: Published in cooperation with the University of …, 2004 | 65 | 2004 |
| The molecular response of vanadium complexes of nicotinoyl hydrazone in cervical cancers—a possible interference with HPV oncogenic markers RS Nair, M Kuriakose, V Somasundaram, V Shenoi, MRP Kurup, ... Life sciences 116 (2), 90-97, 2014 | 53 | 2014 |
| Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) status KAA Thasni, G Rojini, SN Rakesh, T Ratheeshkumar, MS Babu, ... European journal of pharmacology 588 (2-3), 158-164, 2008 | 44 | 2008 |
| Down regulation of endothelial adhesion molecules in node positive breast cancer: possible failure of host defence mechanism M Madhavan, P Srinivas, E Abraham, I Ahmed, NR Vijayalekshmi, ... Pathology Oncology Research 8, 125-128, 2002 | 37 | 2002 |
| Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer SK Sengodan, KH Sreelatha, R Nadhan, P Srinivas Critical reviews in oncology/hematology 123, 74-82, 2018 | 35 | 2018 |
| Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy NR Latha, A Rajan, R Nadhan, S Achyutuni, SK Sengodan, ... Critical Reviews in Oncology/Hematology 151, 102964, 2020 | 33 | 2020 |
| BRCA1 regulation on β-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer SK Sengodan, R Nadhan, RS Nair, SK Hemalatha, V Somasundaram, ... Oncogenesis 6 (9), e376-e376, 2017 | 30 | 2017 |
| Nitric oxide and reactive oxygen species: clues to target oxidative damage repair defective breast cancers V Somasundaram, R Nadhan, SK Hemalatha, SK Sengodan, P Srinivas Critical reviews in oncology/hematology 101, 184-192, 2016 | 30 | 2016 |
